Leucadia National - MARINUS PHARMACEUTICALS INC ownership

MARINUS PHARMACEUTICALS INC's ticker is and the CUSIP is 56854Q200. A total of 89 filers reported holding MARINUS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.3%.

Quarter-by-quarter ownership
Leucadia National ownership history of MARINUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,453,109
-11.1%
304,734
+20.0%
0.02%
-12.0%
Q2 2023$2,758,668
-20.6%
254,021
-49.6%
0.02%
-10.7%
Q1 2023$3,476,172
+76.5%
503,793
+1.8%
0.03%
+100.0%
Q4 2022$1,969,161494,7640.01%
Other shareholders
MARINUS PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Lion Point Capital, LP 2,145,337$17,269,9637.70%
Bleichroeder LP 1,872,463$15,073,3273.72%
SUVRETTA CAPITAL MANAGEMENT, LLC 5,204,942$41,899,7832.26%
Opaleye Management Inc. 584,000$4,701,2001.53%
Bain Capital Life Sciences Investors, LLC 1,431,058$11,520,0171.29%
Cormorant Asset Management, LP 2,625,000$21,131,2501.23%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 290,000$2,337,4000.79%
Ikarian Capital, LLC 746,069$6,005,8560.72%
Eventide Asset Management 4,529,997$36,466,4760.66%
Altium Capital Management LP 125,033$1,006,5160.52%
View complete list of MARINUS PHARMACEUTICALS INC shareholders